-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
BridgeBio Pharma, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2019 to Q3 2024.
- BridgeBio Pharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $27.1M, a 0.36% decline year-over-year.
- BridgeBio Pharma, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $115M, a 14% increase year-over-year.
- BridgeBio Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $115M, a 22.6% increase from 2022.
- BridgeBio Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $93.8M, a 11.1% decline from 2021.
- BridgeBio Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $106M, a 80.6% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)